---
figid: PMC6707069__nihms-1536112-f0008
figtitle: Influence of extracellular HA in erlotinib efficacy using a reductionist
  3D glioblastoma model
organisms:
- NA
pmcid: PMC6707069
filename: nihms-1536112-f0008.jpg
figlink: pmc/articles/PMC6707069/figure/F8/
number: F8
caption: 'Influence of extracellular HA in erlotinib efficacy using a reductionist
  3D glioblastoma model. The epidermal growth factor receptor (EGFR) signaling pathway
  regulates growth, survival and proliferation in GBM through three main signaling
  pathways: JAK/STAT, PI3K/mTOR and Ras/ERK. The addition of erlotinib, together with
  the inhibition of extracellular HA receptor (CD44), downregulates STAT3 phosphorylation,
  only in EGFR+ (GBM12) cells. HA microenvironment also decreases erlotinib faculty
  to stop cell motility in these cells, compared to control, but does not influence
  ERK phosphorylation. PDGFRβ expression is enhanced in GBM6 vIII, upon EGFR inhibition.'
papertitle: Hyaluronic acid-functionalized gelatin hydrogels reveal extracellular
  matrix signals temper the efficacy of erlotinib against patient-derived glioblastoma
  specimens.
reftext: Sara Pedron, et al. Biomaterials. ;219:119371-119371.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9568533
figid_alias: PMC6707069__F8
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC6707069__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6707069__nihms-1536112-f0008.html
  '@type': Dataset
  description: 'Influence of extracellular HA in erlotinib efficacy using a reductionist
    3D glioblastoma model. The epidermal growth factor receptor (EGFR) signaling pathway
    regulates growth, survival and proliferation in GBM through three main signaling
    pathways: JAK/STAT, PI3K/mTOR and Ras/ERK. The addition of erlotinib, together
    with the inhibition of extracellular HA receptor (CD44), downregulates STAT3 phosphorylation,
    only in EGFR+ (GBM12) cells. HA microenvironment also decreases erlotinib faculty
    to stop cell motility in these cells, compared to control, but does not influence
    ERK phosphorylation. PDGFRβ expression is enhanced in GBM6 vIII, upon EGFR inhibition.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ha
  - Hn
  - Egfr
  - Dsor1
  - Mtk
  - ras
  - Ras64B
  - Ras85D
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
  - Crtc
  - Erk7
  - rl
  - EGFR
  - CD44
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - STAT3
  - MTOR
  - RPTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - PDGFRB
  - PDGFRA
  - erlotinib
  - NA
---
